JP2023145633A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023145633A5 JP2023145633A5 JP2023123535A JP2023123535A JP2023145633A5 JP 2023145633 A5 JP2023145633 A5 JP 2023145633A5 JP 2023123535 A JP2023123535 A JP 2023123535A JP 2023123535 A JP2023123535 A JP 2023123535A JP 2023145633 A5 JP2023145633 A5 JP 2023145633A5
- Authority
- JP
- Japan
- Prior art keywords
- rep
- msbi2
- tissue
- seq
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 4
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 101000934372 Homo sapiens Macrosialin Proteins 0.000 claims 1
- 102100025136 Macrosialin Human genes 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 206010020718 hyperplasia Diseases 0.000 claims 1
- 239000000107 tumor biomarker Substances 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19158845.8 | 2019-02-22 | ||
| EP19158845.8A EP3699595A1 (en) | 2019-02-22 | 2019-02-22 | Use of bmmf1 rep protein as a biomarker for breast cancer |
| PCT/EP2020/054613 WO2020169796A1 (en) | 2019-02-22 | 2020-02-21 | Use of bmmf1 rep protein as a biomarker for breast cancer |
| JP2021549295A JP7391980B2 (ja) | 2019-02-22 | 2020-02-21 | 乳がんのバイオマーカとしてのｂｍｍｆ１ ｒｅｐタンパク質の使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549295A Division JP7391980B2 (ja) | 2019-02-22 | 2020-02-21 | 乳がんのバイオマーカとしてのｂｍｍｆ１ ｒｅｐタンパク質の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023145633A JP2023145633A (ja) | 2023-10-11 |
| JP2023145633A5 true JP2023145633A5 (enExample) | 2023-12-28 |
| JP7544930B2 JP7544930B2 (ja) | 2024-09-03 |
Family
ID=65529541
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549295A Active JP7391980B2 (ja) | 2019-02-22 | 2020-02-21 | 乳がんのバイオマーカとしてのｂｍｍｆ１ ｒｅｐタンパク質の使用 |
| JP2023123535A Active JP7544930B2 (ja) | 2019-02-22 | 2023-07-28 | 乳がんのバイオマーカとしてのｂｍｍｆ１ ｒｅｐタンパク質の使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549295A Active JP7391980B2 (ja) | 2019-02-22 | 2020-02-21 | 乳がんのバイオマーカとしてのｂｍｍｆ１ ｒｅｐタンパク質の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220034890A1 (enExample) |
| EP (2) | EP3699595A1 (enExample) |
| JP (2) | JP7391980B2 (enExample) |
| AU (1) | AU2020225036A1 (enExample) |
| CA (1) | CA3124273A1 (enExample) |
| DK (1) | DK3928095T3 (enExample) |
| ES (1) | ES3040185T3 (enExample) |
| WO (1) | WO2020169796A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025518482A (ja) * | 2022-05-11 | 2025-06-17 | ドイチェス クレブスフォルシュンクスツェントルム スチフトゥング デス エッフェントリヒェン レヒツ | 膵臓癌および２型糖尿病のための診断マーカーとしてのｂｍｍｆ１ ｒｅｐタンパク質の使用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6566072B1 (en) * | 1995-05-31 | 2003-05-20 | Washington University | Mammaglobin, a secreted mammary-specific breast cancer protein |
| EP2868751A1 (en) | 2013-10-30 | 2015-05-06 | Deutsches Krebsforschungszentrum | HCBI sequences as an early marker for the future development of cancer and diseases of the CNS and as a target for cancer treatment and prevention |
| EP2966176A1 (en) * | 2014-07-10 | 2016-01-13 | Deutsches Krebsforschungszentrum | HCBI, MSBI, MSSI and CMI sequences as an early marker for the future development of cancer and diseases of the CNS and as a target for the treatment and prevention of these diseases |
| EP3306316A1 (en) * | 2016-10-10 | 2018-04-11 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Rep protein as protein antigen for use in diagnostic assays |
| EP3424942A1 (en) * | 2017-07-07 | 2019-01-09 | Deutsches Krebsforschungszentrum | Improved rep protein for use in a diagnostic assay |
| EP3517960A1 (en) * | 2018-01-30 | 2019-07-31 | Deutsches Krebsforschungszentrum | Use of bmmf rep protein as biomarker for colon cancer |
| EP3653702A1 (en) * | 2018-11-15 | 2020-05-20 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Crystal structure of a replication protein encoded by a plasmid isolated from a multiple sclerosis patient |
-
2019
- 2019-02-22 EP EP19158845.8A patent/EP3699595A1/en not_active Withdrawn
-
2020
- 2020-02-21 WO PCT/EP2020/054613 patent/WO2020169796A1/en not_active Ceased
- 2020-02-21 DK DK20708393.2T patent/DK3928095T3/da active
- 2020-02-21 AU AU2020225036A patent/AU2020225036A1/en active Pending
- 2020-02-21 CA CA3124273A patent/CA3124273A1/en active Pending
- 2020-02-21 ES ES20708393T patent/ES3040185T3/es active Active
- 2020-02-21 EP EP20708393.2A patent/EP3928095B1/en active Active
- 2020-02-21 JP JP2021549295A patent/JP7391980B2/ja active Active
-
2021
- 2021-08-10 US US17/444,778 patent/US20220034890A1/en active Pending
-
2023
- 2023-07-28 JP JP2023123535A patent/JP7544930B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2003085399A1 (ja) | 白血病、前白血病または非白血病性悪性血液疾患の判定方法及び診断薬 | |
| JP2012509295A5 (enExample) | ||
| JP2020528138A5 (enExample) | ||
| ES2351938T3 (es) | Reactivos y métodos para su uso en el diagnóstico, clasificación y terapia del cáncer . | |
| JP2021513658A (ja) | 大腸癌のバイオマーカとしてのｂｍｍｆ１ ｒｅｐタンパク質の使用 | |
| JP2023145633A5 (enExample) | ||
| JP5453667B2 (ja) | 動脈硬化症の検出方法及び動脈硬化症マーカー | |
| JP7324300B2 (ja) | 前立腺がんのバイオマーカとしてのｂｍｍｆ１ ｒｅｐタンパク質の使用 | |
| CN101735317A (zh) | Cathepsin D抗原多肽、应用及含有该多肽的检测试剂盒 | |
| CN115707784A (zh) | Usp10在非小细胞肺癌患者的诊断和预后评估中的应用 | |
| JP7544930B2 (ja) | 乳がんのバイオマーカとしてのｂｍｍｆ１ ｒｅｐタンパク質の使用 | |
| CN114874319B (zh) | 一种用于急性肾损伤检测的cryab抗体及其应用 | |
| JP2007176872A (ja) | アシンメトリックジメチルアルギニンを認識する抗体及びその製造方法並びに翻訳後修飾アミノ酸含有タンパク質の検出方法 | |
| JP4576168B2 (ja) | 膀胱尿管逆流症または間質性膀胱炎の検査方法 | |
| CN106220722B (zh) | Dkk1自身抗体识别的抗原多肽及其用途 | |
| CN103848889B (zh) | Igf2bp1自身抗体识别的抗原多肽 | |
| CN101974088A (zh) | 乳腺珠蛋白单克隆抗体及其在乳腺癌诊断中的应用 | |
| US20070141600A1 (en) | ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis | |
| JP5366234B2 (ja) | 扁平上皮がんに対する放射線治療後における予後の予測方法および予後予測用キット | |
| AU2005290997B2 (en) | Novel cancer associated antibodies and antigens and their use in cancer diagnosis | |
| KR102281512B1 (ko) | TGFBIp의 아세틸화 수준을 측정하는 제제를 포함하는 염증성 질환 진단용 조성물 | |
| CN103848891B (zh) | Ccnd1自身抗体识别的抗原多肽 | |
| JP2009221225A (ja) | 精神分裂病の診断のための新規ペプチド | |
| WO2011030300A1 (en) | Synthetic peptides from the sv40 t-antigen for use in an indirect elisa test for the identification of antibodies against simian virus 40 in human serum and other fluids | |
| JP5626681B2 (ja) | 癌の検出方法 |